Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy.
Ciancio G, Carreno M, Mathew J, Ricordi C, Garcia R, Karatzas T, Fuller L, Cirocco R, Burke G, Webb M, Nery J, Tzakis A, Roth D, Esquenazi V, Miller J.
Ciancio G, et al. Among authors: miller j.
Transplant Proc. 1996 Apr;28(2):943-4.
Transplant Proc. 1996.
PMID: 8623473
Clinical Trial.
No abstract available.